Clinical Trial Update: Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating biphasic insulin aspart 30 and 70 in adults with Type 1 diabetes, assessing absorption and exposure characteristics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)
• Biphasic insulin aspart 70 (insulin aspart, biphasic 70/30)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED